BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20578260)

  • 21. Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target.
    Holtzman NG; Lebowitz MS; Koka R; Baer MR; Malhotra K; Shahlaee A; Ghanbari HA; Bentzen SM; Emadi A
    Front Oncol; 2021; 11():783744. PubMed ID: 35004304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-organ metastasis as destination for breast cancer cells guided by biomechanical architecture.
    Lin Q; Chen X; Meng F; Ogawa K; Li M; Song R; Zhang S; Zhang Z; Kong X; Xu Q; He F; Liu D; Bai X; Sun B; Hung MC; Liu L; Wands JR; Dong X
    Am J Cancer Res; 2021; 11(6):2537-2567. PubMed ID: 34249415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of 2-oxoglutarate derivatives and their evaluation as cosubstrates and inhibitors of human aspartate/asparagine-β-hydroxylase.
    Brewitz L; Nakashima Y; Schofield CJ
    Chem Sci; 2020 Dec; 12(4):1327-1342. PubMed ID: 34163896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatocellular Carcinoma: Single-Center Analyses With Internal Validation.
    Yang J; Zhu S; Yong J; Xia L; Qian X; Yang J; Hu X; Li Y; Wang C; Peng W; Zhang L; Deng M; Pan W
    Front Oncol; 2021; 11():616976. PubMed ID: 33747929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COCH predicts survival and adjuvant TACE response in patients with HCC.
    Wang C; Ding ZW; Zheng CG; Wang S; Li ZH; Zhang ZM; Pan J; Wang J; Yang C
    Oncol Lett; 2021 Apr; 21(4):275. PubMed ID: 33732351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
    Yang Y; Lin K; Liu L; Qian Y; Yang Y; Yuan S; Zhu P; Huang J; Liu F; Gu F; Fu S; Jiang B; Liu H; Pan Z; Lau WY; Zhou W
    Cancer Med; 2021 Mar; 10(6):2100-2111. PubMed ID: 33650288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel inflammation-based prognostic nomograms for individualized prediction in hepatocellular carcinoma after radical resection.
    Zeng J; Zeng J; Wu Q; Lin K; Zeng J; Guo P; Zhou W; Liu J
    Ann Transl Med; 2020 Sep; 8(17):1061. PubMed ID: 33145280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diverse molecular functions of aspartate β‑hydroxylase in cancer (Review).
    Zheng W; Wang X; Hu J; Bai B; Zhu H
    Oncol Rep; 2020 Dec; 44(6):2364-2372. PubMed ID: 33125119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small-molecule active pharmaceutical ingredients of approved cancer therapeutics inhibit human aspartate/asparagine-β-hydroxylase.
    Brewitz L; Tumber A; Zhang X; Schofield CJ
    Bioorg Med Chem; 2020 Oct; 28(20):115675. PubMed ID: 33069066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Next-generation des-r-carboxy prothrombin for immunohistochemical assessment of vascular invasion by hepatocellular carcinoma.
    Yamazaki S; Takayama T; Kurokawa T; Shimamoto N; Mitsuka Y; Yoshida N; Higaki T; Sugitani M
    BMC Surg; 2020 Sep; 20(1):201. PubMed ID: 32928172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspartate β-hydroxylase as a target for cancer therapy.
    Kanwal M; Smahel M; Olsen M; Smahelova J; Tachezy R
    J Exp Clin Cancer Res; 2020 Aug; 39(1):163. PubMed ID: 32811566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammation Score System using Preoperative Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma after Hepatectomy: A Cohort Study.
    Chen Q; Li F; Zhong C; Zou Y; Li Z; Gao Y; Zou Q; Xia Y; Wang K; Shen F
    J Cancer; 2020; 11(17):4947-4956. PubMed ID: 32742442
    [No Abstract]   [Full Text] [Related]  

  • 33. Prognostic Significance of Elevated Preoperative Serum CA125 Levels After Curative Hepatectomy for Hepatocellular Carcinoma.
    Huang Y; Zeng J; Liu T; Lin X; Guo P; Zeng J; Zhou W; Liu J
    Onco Targets Ther; 2020; 13():4559-4567. PubMed ID: 32547086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of Novel Pyridine-Carboxylates as Small-Molecule Inhibitors of Human Aspartate/Asparagine-β-Hydroxylase.
    Brewitz L; Tumber A; Thalhammer A; Salah E; Christensen KE; Schofield CJ
    ChemMedChem; 2020 Jul; 15(13):1139-1149. PubMed ID: 32330361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    Cancer Lett; 2020 Jul; 481():63-75. PubMed ID: 32145343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis.
    Lin Q; Chen X; Meng F; Ogawa K; Li M; Song R; Zhang S; Zhang Z; Kong X; Xu Q; He F; Bai X; Sun B; Hung MC; Liu L; Wands J; Dong X
    Mol Cancer; 2019 Nov; 18(1):156. PubMed ID: 31694640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspartate/asparagine-β-hydroxylase crystal structures reveal an unexpected epidermal growth factor-like domain substrate disulfide pattern.
    Pfeffer I; Brewitz L; Krojer T; Jensen SA; Kochan GT; Kershaw NJ; Hewitson KS; McNeill LA; Kramer H; Münzel M; Hopkinson RJ; Oppermann U; Handford PA; McDonough MA; Schofield CJ
    Nat Commun; 2019 Oct; 10(1):4910. PubMed ID: 31659163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HBV DNA levels impact the prognosis of hepatocellular carcinoma patients with microvascular invasion.
    Li L; Li B; Zhang M
    Medicine (Baltimore); 2019 Jul; 98(27):e16308. PubMed ID: 31277172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral therapy predicts the outcomes following resection of hepatocellular carcinoma in patients negative for HBV DNA: a propensity score matching analysis.
    Xu M; Zhou Z; Xu R; Zhang H; Lin N; Zhong Y
    World J Surg Oncol; 2019 Mar; 17(1):45. PubMed ID: 30823932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma.
    Nagaoka K; Bai X; Ogawa K; Dong X; Zhang S; Zhou Y; Carlson RI; Jiang ZG; Fuller S; Lebowitz MS; Ghanbari H; Wands JR
    Cancer Lett; 2019 May; 449():87-98. PubMed ID: 30768955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.